Turnstone Biologics (TSBX) - 2025 Q2 - Quarterly Report

(Mark One) UNITED STATES SECURITIES AND EXCHANGE COMMISSION ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Washington, D.C. 20549 FORM 10-Q OR For the quarterly period ended June 30, 2025 (Exact name of registrant as specified in its charter) ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Delaware 83-2909368 (State or other jurisdiction of incorporation or organization) (I.R.S. Employer Identification No.) 1110 North Virg ...